Stephen Basil Thomas

Director, Climb Bio, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.2M

Companies

Latest trade

Sep 15, 2026

Companies

Climb Bio, Inc.Director −$2.2M

Trades

CLYM Sold 100,000 shares at $13.67 · planned $1.4M Sep 15

CLYM Sold 16,313 shares at $7.01 · planned $0.1M Feb 26

CLYM Sold 33,687 shares at $7.00 · planned $0.2M Feb 25

CLYM Sold 10,000 shares at $5.81 · planned $0.1M Feb 13

CLYM Sold 90,000 shares at $5.23 · planned $0.5M Feb 12

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.